Jp. Williams et al., TYROSINE-PHOSPHORYLATED CALMODULIN HAS REDUCED BIOLOGICAL-ACTIVITY, Archives of biochemistry and biophysics, 315(1), 1994, pp. 119-126
Calmodulin is phosphorylated by the purified insulin receptor on tyros
ine residues with a maximum stoichiometry of 1 mol phosphate/mol of ca
lmodulin. Isolated tryptic phosphopeptides were sequenced by manual Ed
man degradation and demonstrated that calmodulin is equally phosphoryl
ated on tyrosine 99 and tyrosine 138. Phosphorylated calmodulin has a
decreased affinity (K-0.5 = 4.2 nM) for the 63-kDa isozyme of cyclic n
ucleotide phosphodiesterase compared to nonphosphorylated calmodulin (
K-0.5 = 2.1 nM). The K-0.5 for Ca2+ is marginally increased from 2.8 t
o 3.2 mu M in the presence of phosphotyrosyl calmodulin. The effect of
the calmodulin antagonist, mastoparan, was investigated to determine
whether mastoparan would differentially inhibit calmodulin- or phospho
calmodulin-dependent enzyme activity. The IC50 of mastoparan is fourfo
ld lower for phosphotyrosyl calmodulin compared to nonphosphorylated c
almodulin. Phosphorylation of calmodulin may provide a mechanism for t
he differential regulation of calmodulin-dependent enzymes. These obse
rvations further support a potentially important regulatory function o
f calmodulin phosphorylation in signal transduction. (C) 1994 Academic
Press, Inc.